Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RVD Induction and Randomized Mobilization in Multiple Myeloma
NCT01790737Phase 2Completed
- Sponsor
- Kuopio University Hospital
- Start
- Jan 2013
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide in multiple myeloma (MM), sponsored by Kuopio University Hospital. Started Jan 2013; status: completed.
02
Drugs
cyclophosphamide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01790737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01790737.